New open-access Translational Psychiatry paper: multi-omic integration + drug repurposing to identify FDA-approved treatments for opioid use disorder. Led by POP-GEM’s @BToddWebb. Approach generalizable across complex traits & disorders.
https://t.co/tNEaSrM9Lw
#OUD
🚨 Just submitted!
Led by @MufalhHassan, we used ML to predict alcohol consumption via biomarkers in the UK Biobank.
🔑 Key points:
✅ ML > Traditional methods
✅ Biomarkers improve accuracy
✅ Explainable AI reveals risks
Stay tuned!
@AmandaEGentry@PetersonRoseann@BToddWebb
1/1,The POP-GEM Lab is heading to #ASHG2024 in Denver (Nov 5-9)! Don’t miss out on the groundbreaking work our team will be presenting. Come check out our posters showcasing advancements in genetic research. #ASHG24#GeneticsResearch@sunydownstate@RTI_Intl@VCU_VIPBG 👇
Don’t miss out! 🧬 Team member Tan-Hoang Nguyen will be presenting on rare variant analysis for PTSD using whole-exome sequencing data! 🧪Join us on 11/08 for insights into #Genomics and #PTSDResearch at #ASHG2024!
A statement on the need for scientific rigor in the development of genetic tests, endorsed by @ISPGnet and signed by 140 experts in the field:
Concerns about genetic risk testing for opioid use disorder - The Lancet Psychiatry https://t.co/SwR4sdNtip
5/5🔬Peter Barr, @pbb2 will be presenting a multivariate genomic investigation of the externalizing spectrum and suicide risk at #WCPG2024. Don’t miss it!🗓️ October 16th | 🕟 4:30 - 6:00 PM #Genomics#SuicidePrevention#PsychiatryResearch
4/4🚀 Don’t miss @AmandaEGentry's poster on how MAGIC-XGBoost enhances unmeasured phenotype prediction and genomic discoveries of MDD in the UK Biobank!🗓️ 10/16 | 🕟 4:30 - 6:00 PM #Genomics#PsychiatryResearch#WCPG2024
3/3💡 @Madhur_B_Singh also sharing research on MDD from cross-ancestry genome-wide analyses in the UK Biobank! Discover enhanced genomic insights into major depressive disorder. 🗓️ 10/16 | 🕐 1:15 - 1:30 PM 🧠 #Psychiatry#GeneticsResearch
2/2 First up, POP-GEM Lab Director @petersonroseann presenting our work on the Trans-Ancestry GWAS Pipeline, empowering genomic discovery in large-scale EHR-linked biobanks! Learn more about MDD insights from the PsycheMERGE Diversity Initiative.
🗓️ 10/16 | 🕐 1:00 - 1:15 PM 🧬
1/1 Excited to kick off #WCPG2024 in Singapore! The POP-GEM Team will be presenting our latest findings on genetic and environmental influences on mental health. Stay tuned for updates! 🧬🧵👇
PSA, since I've now seen problems arising from this: As of Sept 2023, GATK no longer makes missing genotypes explicit in VCFs (i.e. "./." as in the VCF spec). Missing genotypes are instead coded as "0/0" with a DP=0 format field. See attached for examples.
Happy to share two new preprints from our group at @RTI_Intl and collaborators covering DNA methylation and gene expression differences associated with alcohol use disorder in human brain.
https://t.co/WgraRjP7nJ
https://t.co/jUe8Accbbl
Here's a new preprint from our group.
"Identifying compounds to treat opiate use disorder by leveraging multi-omic data integration and multiple drug repurposing databases." https://t.co/hheSg4cHx6 @carynwillis94@bryancquach@RTI_Intl